Dr Aleksandra Singh

Dr. Aleksandra Singh serves as the Oligonucleotide Synthesis Lead, with a distinguished background in cancer research. She earned her PhD from the Francis Crick Institute in London and holds an MRes in Translational Cancer Medicine from King’s College London. Dr. Singh has been the principal investigator on over 15 large international collaborative projects, underscoring her leadership in the scientific community. Her research has been widely recognized and published in prestigious journals including Current Biology, Cell, and Nature Medicine. Additionally, her work has led to multiple patent applications, demonstrating her innovative approach in the field. Dr. Singh’s achievements were acknowledged when she was listed on Forbes’ 30 under 30 in Science and Healthcare in 2018, highlighting her as a leading figure in medical science research.